Can dextran-based nanoparticles mitigate inflammatory lung diseases?

Parteek Prasher; Mousmee Sharma; Peter R Wich; Niraj Kumar Jha; Sachin Kumar Singh; Dinesh K. Chellappan; Kamal Dua

doi:10.4155/fmc-2021-0218

Can dextran-based nanoparticles mitigate inflammatory lung diseases?

Parteek Prasher
, Mousmee Sharma
, Peter R Wich
, Niraj Kumar Jha
, Sachin Kumar Singh
, Dinesh K. Chellappan
, Kamal Dua

University of Petroleum and Energy Studies
Uttaranchal University
University of New South Wales
Sharda University
Lovely Professional University
International Medical University
University of Technology Sydney

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	2027-2031
Number of pages	5
Journal	Future Medicinal Chemistry
Volume	13
Issue number	23
DOIs	https://doi.org/10.4155/fmc-2021-0218
State	Published - Dec 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

acetalated dextran
aerosolized formulations
dextran
dry powder inhalers
mucus permeation
nanocomposite microparticle (nCmP)
pulmonary delivery
respiratory diseases
siRNA delivery
theranostics

Access to Document

10.4155/fmc-2021-0218

Cite this

@article{253d82d0489140da85ed10971d6bb815,

title = "Can dextran-based nanoparticles mitigate inflammatory lung diseases?",

keywords = "acetalated dextran, aerosolized formulations, dextran, dry powder inhalers, mucus permeation, nanocomposite microparticle (nCmP), pulmonary delivery, respiratory diseases, siRNA delivery, theranostics",

author = "Parteek Prasher and Mousmee Sharma and \{R Wich\}, Peter and Jha, \{Niraj Kumar\} and Singh, \{Sachin Kumar\} and Chellappan, \{Dinesh K.\} and Kamal Dua",

year = "2021",

month = dec,

doi = "10.4155/fmc-2021-0218",

language = "English",

volume = "13",

pages = "2027--2031",

journal = "Future Medicinal Chemistry",

issn = "1756-8919",